GMI joins the battle to beat rare disorders in conjunction with Temple Street Hospital with our new study which kicked off yesterday. This issue was highlighted on The Pat Kenny Show yesterday morning featuring Professor Mary King and Angelina Ryan who is the mother of baby Ava whose life was cut short by a rare epilepsy. Listen in to the highlights from the programme to learn more.
Study Will Employ Advanced Technology to Explore Genetic Factors In Rare Conditions
Dublin, 28th February, 2017: Irish life-sciences company, Genomics Medicine Ireland Ltd. (GMI) has partnered with Temple Street Children’s University Hospital and the UCD Academic Centre on Rare Diseases (ACoRD) to launch a groundbreaking research study which will examine children with rare undiagnosed genetic disorders attending Temple Street, and their parents in order to identify the key genetic components of rare disorders. The study will combine advanced scientific technology in genomics, the study of all of a person’s genes, together with detailed clinical information to identify the genetic cause of rare disorders affecting/amongst families in Ireland. Read More
GMI co-founder, Dr. Sean Ennis, will be speaking at the national Rare Disease Day on Tuesday 28th February at the Royal Hospital Kilmainham, Dublin 8.
The event seeks to raise awareness of the impact that rare diseases have on the lives of patients and those who care for them. The theme of this year’s day is research.
Genomics Medicine Ireland CEO, Dan Crowley, will be sharing his views of the future at the “Making Digital Transformation Something Everyone Can Be a Part of” panel at the Dublin Tech Summit on Wednesday, 15th Feb at 16.30. The Dublin Tech Summit (DTS) is an international technology conference which is held at the Convention Centre Dublin in the city’s “Silicon Docks”.
DTS 2017 will bring together global leaders in innovation, technology and business to shape the future of global trends and technologies. MedTech is one of the eight core themes which participants will hear about from leaders shaping the future of industry. http://dublintechsummit.com/
GMI Co-Founder, Maurice Treacy, will be speaking on a panel Thursday at the RebelBio Future: Building a Better World conference (Formerly SynBioFuture). The conference features a line-up of influential speakers who will explore how synthetic biology can help make our world a better place. The conference begins at 8:00AM February 9th in Devere Hall, University College Cork and runs until 17:00, followed by a reception in the historic Aula Maxima.
Effort will sequence the genomes of 45,000 participants from across Ireland to identify novel targets and advance the clinical development of better treatments for a range of serious diseases
- Focus is on key AbbVie therapeutic areas including oncology, neuroscience and immunology
- Genomics Medicine Ireland will partner with Ireland’s leading clinicians and researchers and propel bioscience innovation in Ireland
- WuXi NextCODE’s integrated genomics platform will be used to organise and mine a secure, scalable database of whole genome sequence and medical data to power novel disease insights
Genomics Medicine Ireland Co-Founder, Dr. Sean Ennis, will be speaking at the Sidra international conference and symposium in collaboration with Nature Genetics in Doha, Qatar 11-13 December. The conference theme is Nature versus Nurture.
In this symposium, world-renowned scientists and clinicians will present state-of-the-art scientific discoveries, will address the interactions between nature and nurture and how the genetic patterns may be altered by a life experience, nutrition as well as the surrounding environment. The symposium will also address how these interactions are tackled and implemented in health care.
An exhibition from world-leading technology and service providers will run in parallel with the symposium presentations.
This symposium is organised as part of the Sidra Symposia Series and is directed towards academia, researchers, physicians, healthcare providers and regulatory agents involved in the field of genomics and genomic medicine.